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Abstract
Introduction: Urinary tract infection (UTI) is the 
commonest bacterial infection occurring in renal 
transplant recipients, and it is associated with significant 
morbidity. This study aimed to assess the characteristics 
of all UTI episodes diagnosed in renal transplant patients 
who attended regularly for follow up in the nephrology 
department of National Heart Center, Tripoli, Libya. 
Methods: Data were collected by retrospective review 
of patients' medical records. UTI was defined as a urine 
culture containing more than 105 colonies/ml and pyuria 
(10 leukocytes /HPF).
Results: Out of a total of 112 kidney transplant patients, 
UTI was diagnosed in 33 patients (29.5%). The mean 
age of affected patients was 43±20 years with a range of 
20-63 years. Most of the episodes (72%) occurred during 
the first 3 months after transplantation, and 60.6% of 
affected patients had more than one episode of infection. 
A larger proportion of females were affected than 
males (40.8% versus 20.6% respectively, P=0.02). No 
significant difference was detected in the proportion of 
affected patients whether the donor was live-unrelated or 
live-related (32.3% versus 28.4% respectively, P=0.43). 
The commonest causative microorganism was E. coli 
(38.7%), followed by klebsiella (25.8%), Staphylococcus 
(25.8%), and others (9.7%). The commonest drug used 
for treatment was ciprofloxacin (51.6%), followed 
by amoxicillin-clavulinic acid (22.6%), meropenem 
(12.9%), and others (12.9%). 
Conclusion: The prevalence of UTI in our cohort 
of patients is similar to that reported by others. The 
commonest causative agent was E. coli, and ciprofloxacin 
was the most commonly used drug. 
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Introduction
Urinary tract infection (UTI) is the most common 
infection seen after kidney transplantation,  it is seen in 
30-40% of recipients during the first four months after 
transplantation [1, 2].  Although different studies reported 
widely varying incidence rates, the majority of organisms 
cultured were Gram-negative (76%) with approximately 
33% being caused by E. coli and 20% by Enterococcus 
and Klebsiella enterobacter. Gram-positive organisms 
are involved less frequently [3]. Reported isk factors for 
UTI include advanced age, female gender, reflux kidney 
disease, cadaveric donor, pre-transplantation UTI, 
prolonged period of hemodialysis, polycystic kidney 
disease, diabetes mellitus, prolonged postoperative 
bladder catheterization, immunosuppression, allograft 
trauma, and technical complications associated with 
ureteral anastomosis [3, 4].  Recurrence or re-infection 
is a common occurrence. The impact of UTI on graft 
survival and patient mortality was variable, Memikoğlu 
et al [5] study showed that there was a tendency towards 
graft loss among patients with UTI, but there was no 
increased risk of death, while Chuang et al [4] study 
showed the opposite effects. A recent large data analysis 
of the United States Renal Data System (USRDS) has 
shown that late UTI in adult renal transplant recipients 
is associated with a higher risk of both graft loss and 
patient death [6]. In adults, UTI after transplantation has 
been associated with significant morbidity that appears to 
be related to the time of occurrence of the infection after 
transplantation [7].
This study aimed to identify the prevalence, the causative 
microorganisms, and the drugs used for the treatment 
of UTI in renal transplant patients in the nephrology 
department of National Heart Center, Tripoli, Libya.
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Table 1: Gender and type of kidney donor of kidney transplant patients affected by urinary tract infections (UTI), compared 
to patients not affected with UTI
Patient characteristics No UTI (N=79) UTI (N=33) P value
Gender Male 50 (79.4%) 13 (20.6%) 0.02*
Female 29 (59.2%) 20 (40.8%)
Donor relation Live-related 58 (71.6%) 23 (28.4%) 0.43
Live-unrelated 21 (67.7%) 10 (32.3%)
* Statistically significant
Methods
The medical records of transplanted patients were studied 
retrospectively. According to local protocols, transplant 
patients are followed up weekly for the first 3 months 
after transplantation, then twice monthly for the next three 
months, then monthly for the rest of their lives. During 
follow up visits, patients are asked about symptoms of 
UTI, and routine laboratory investigations include urine 
analysis. Urine culture and abdominal ultrasound scans 
are requested if symptoms or signs of UTI are noticed. 
UTI is defined as a urine culture containing more than 
105 colonies/ml and pyuria (10 leukocytes /HPF).
Treatment of UTI was modified according to culture and 
sensitivity results. Evaluation of treatment results was 
done after one week by further clinical evaluation and by 
repeating urinalysis and culture.  
Minitab (Version 15) was used for statistical analysis and 
percentages were compared using Chi square test. 
Results
The total number of patients under regular follow up in 
the center was 112 patients. There were 63 males and 49 
females. Transplants were from live-related donors in 31 
patients and from live-unrelated donors in 81 patients. 
UTI was diagnosed in 33 patients (29.5%); their mean 
age was 43±20 years with a range of 20-63 years. Some 
clinical criteria of affected patients are outlined (Table 
1). Most of UTI cases (72%) occurred during the first 
3 months after transplantation, and 60.6% of affected 
patients had more than one episode of infection. 
Gram-negative bacteria were the commonest isolated 
microorganisms; E. coli was isolated in 38.7% of cases, 
followed by klebsiella (25.8%), Staphylococcus (25.8%), 
and other organisms (9.7%). The commonest drug used 
for treatment was ciprofloxacin (51.6%), followed by 
amoxicillin-clavulinic acid (22.6%), meropenem (12.9%) 
and others (12.9%).
Discussion 
In our patients' population the prevalence rate of UTI 
was 29.5%. Female recipients were reported to be at a 
greater risk for development of UTI than males [3, 5, 7], 
although Nazemian et al [8] found no correlation between 
prevalence of UTI and the gender of the recipient. In our 
patients, the proportion of affected females was higher 
than the proportion of males (40.8% versus 20.6%, 
P=0.02). Gram-negative bacteria were reported as the 
commonest causative organisms [3, 8]. In our study 
Gram-negative bacteria were isolated in 65% of cases. E. 
coli was involved in 38.7% of the cases which is slightly 
higher than the prevalence reported by Taki et al [3] but 
less than the prevalence reported by others [5, 9]. In our 
results klesiella was involved in 25.8% of cases which 
is more than the prevalence reported by Memikoğlu et 
al [5] but less than the prevalence reported by others 
[9]. The commonest drug used for the treatment was 
ciprofloxacin which gave a good response in most of 
the cases; the same response was reported by Grekas et 
al [10]. However, high resistance rates of E. coli strains 
against ciprofloxacin were described by Senger et al 
[11].
Conclusions
The prevalence of urinary tract infection in our group 
of renal transplant recipients is similar to that reported 
by others and is commoner in females. The commonest 
causative agent was E. coli, and ciprofloxacin was the 
most commonly used drug.                                 
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